Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
HIV/AIDS Blog Central

Study Finds That PReP Acceptance Depends on Cost Instead of Effectiveness

By Candace Y.A. Montague

June 8, 2011

PReP is more effective when it costs less. Credits: taf.org.

PReP is more effective when it costs less. Credits: taf.org.

A study out of UCLA and Lima, Peru show that people are more willing to use Truvada, the anti-retroviral drug for HIV, if they can pay less money for it regardless of its effectiveness. The International Study of STD and AIDS published the results of the study last week. Using consumer marketing techniques, the study found that female sex workers, male-to-female transgender persons and men who have sex with men would be willing to take the pill if the cost to purchase it was low. The participants also said that they would be willing to take the pill if it were 100 percent effective and only required to be taken right before sex. The results from the scientific research published earlier this year showed that in order for the pill to be effective, participants would have to take it daily regardless of sexual activity and it only cuts the risk of infection by 44%.

These expectations are not surprising to this Examiner who wondered about the cost of this treatment in an earlier report. Health educators want to have effective treatment that would in fact prevent HIV transmission. But out-of-pocket cost has a direct effect on accessibility. If a person wants to protect themselves from contracting the virus, chances are they will not spend more than what they do on a three pack of condoms to get that protection. It's just not feasible. Other factors weighed in on the participants willingness to use PReP including where they would be willing to go to pick up the pill, side effects, and the duration of use. Health care must be made more affordable and more opportune on all levels if we expect to stop the virus.

For more information about the study click here.

Send Candace an e-mail.

Get e-mail notifications every time Candace's blog is updated.

See Also
More News and Research on HIV Medications for HIV Prevention

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:
BLOG:
D.C. HIV/AIDS Examiner


Candace Y.A. Montague

Candace Y.A. Montague

Candace Y.A. Montague has been learning about HIV since 1988 (and she has the certificates from the American Red Cross to prove it). Health is a high priority to Candace because she believes that nothing can come of your life if you're not healthy enough to enjoy it. One of her two master's degrees is in Community Health Promotion and Education. Candace was inspired to act against HIV after seeing a documentary in 2008 about African-American women and HIV. She knew that writing was the best way for her to make a difference and help inform others. Candace is a native Washingtonian and covers HIV news all around D.C. She has covered fundraisers, motorcycle rides, town hall meetings, house balls, Capitol Hill press conferences, election campaigns and protests for The DC Examiner.com and emPower News Magazine.

Follow Candace on Twitter

Friend Candace on Facebook


Subscribe to Candace's Blog:

Subscribe by RSSBy RSS ?

Subscribe by Email


Recent Posts:

View All Posts


A Brief Disclaimer:

The opinions expressed by TheBody.com's bloggers are entirely their own, and do not necessarily reflect the views of TheBody.com itself.

Advertisement